Cabozantinib
A multi-tyrosine kinase inhibitor, used (as its malate salt) for the treatment of progressive, metastatic, medullary thyroid cancer. It has a role as a tyrosine kinase inhibitor and an antineoplastic agent.
| Catalog Number | API849217681 |
| Alternative Name(s) | XL184 Cometriq XL-184 |
| Research Area | Anti-Tumor APIs |
| Molecular Formula | C28H24FN3O5 |
| CAS# | 849217-68-1 |
| SMILES | COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/cabozantinib-item-11876.html |